SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-075144
Filing Date
2021-03-10
Accepted
2021-03-09 19:41:01
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d16997ds3.htm S-3 462800
2 EX-4.10 d16997dex410.htm EX-4.10 296800
3 EX-4.13 d16997dex413.htm EX-4.13 108618
4 EX-4.14 d16997dex414.htm EX-4.14 110942
5 EX-4.15 d16997dex415.htm EX-4.15 97616
6 EX-5.1 d16997dex51.htm EX-5.1 29392
7 EX-23.1 d16997dex231.htm EX-23.1 2444
8 GRAPHIC g16997g0122142314988.jpg GRAPHIC 2403
9 GRAPHIC g16997g05h66.jpg GRAPHIC 40046
  Complete submission text file 0001193125-21-075144.txt   1168385
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254063 | Film No.: 21727695
SIC: 2834 Pharmaceutical Preparations